[177Lu]Lu-FF58

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-FF58, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. [Phase 1]